FLD
Price
$0.51
Change
-$0.01 (-1.92%)
Updated
Oct 22 closing price
Capitalization
27.98M
18 days until earnings call
Intraday BUY SELL Signals
MDBH
Price
$1.76
Change
-$0.01 (-0.56%)
Updated
Oct 22 closing price
Capitalization
18.37M
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FLD vs MDBH

FLD vs MDBH Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
FLD vs. MDBH commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FLD is a Hold and MDBH is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for FLD with price predictions
Oct 22, 2026

FLD in +2.12% Uptrend, rising for three consecutive days on October 21, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where FLD advanced for three days, in 56 of 121 cases, the price rose further within the following month. The odds of a continued upward trend are 46%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FLD as a result. In 34 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 40%.

The Moving Average Convergence Divergence Histogram (MACD) for FLD turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 17 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 37%.

FLD moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FLD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.

The Aroon Indicator for FLD entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.895) is normal, around the industry mean (3.532). P/E Ratio (-0.357) is within average values for comparable stocks, (8.846). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (7.708) among similar stocks. P/S Ratio (0.896) is also within normal values, averaging (16.763).

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. FLD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FLD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

A.I.Advisor
a Summary for MDBH with price predictions
Oct 22, 2026

MDBH's Indicator enters downward trend

The Aroon Indicator for MDBH entered a downward trend on October 22, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 150 similar instances where the Aroon Indicator formed such a pattern. In 138 of the 150 cases the stock moved lower. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDBH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MDBH's RSI Indicator exited the oversold zone, 17 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

MDBH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.370) is normal, around the industry mean (3.532). P/E Ratio (-0.811) is within average values for comparable stocks, (8.846). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (7.708) among similar stocks. P/S Ratio (5.038) is also within normal values, averaging (16.763).

The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. MDBH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDBH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

TECHNICAL ANALYSIS
Technical Analysis
FLDMDBH
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
45%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
40%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
37%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
52%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
46%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
65%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (FLD: $0.52 vs. MDBH: $1.77)
Brand notoriety: FLD and MDBH are both not notable
Both companies represent the Investment Banks/Brokers industry
Current volume relative to the 65-day Moving Average: FLD: 18% vs. MDBH: 256%
Market capitalization -- FLD: $27.98M vs. MDBH: $18.37M
FLD [@Investment Banks/Brokers] is valued at $27.98M. MDBH’s [@Investment Banks/Brokers] market capitalization is $18.37M. The market cap for tickers in the [@Investment Banks/Brokers] industry ranges from $590 to $293.71B. The average market capitalization across the [@Investment Banks/Brokers] industry is $11.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FLD’s FA Score shows that 0 FA rating(s) are green while MDBH’s FA Score has 0 green FA rating(s).

  • FLD’s FA Score: 0 green, 5 red.
  • MDBH’s FA Score: 0 green, 5 red.
According to our system of comparison, FLD is a better buy in the long-term than MDBH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FLD’s TA Score shows that 2 TA indicator(s) are bullish while MDBH’s TA Score has 3 bullish TA indicator(s).

  • FLD’s TA Score: 2 bullish, 5 bearish.
  • MDBH’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, MDBH is a better buy in the short-term than FLD.

Price Growth

FLD (@Investment Banks/Brokers) experienced а +2.10% price change this week, while MDBH (@Investment Banks/Brokers) price change was +1.14% for the same time period.

The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was -5.09%. For the same industry, the average monthly price growth was -16.78%, and the average quarterly price growth was -13.10%.

Reported Earning Dates

FLD is expected to report earnings on Nov 09, 2026.

MDBH is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Investment Banks/Brokers (-5.09% weekly)

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

View a ticker or compare two or three
FLD
Daily Signal:
Gain/Loss:
MDBH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

FLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, FLD has been loosely correlated with BTCS. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if FLD jumps, then BTCS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FLD
1D Price
Change %
FLD100%
-2.07%
BTCS - FLD
35%
Loosely correlated
-3.51%
DEFT - FLD
32%
Poorly correlated
-0.41%
HOOD - FLD
30%
Poorly correlated
-5.25%
SBET - FLD
30%
Poorly correlated
-5.87%
BMNR - FLD
29%
Poorly correlated
-6.09%
More

MDBH and

Correlation & Price change

A.I.dvisor tells us that MDBH and SOS have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MDBH and SOS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDBH
1D Price
Change %
MDBH100%
-0.56%
SOS - MDBH
30%
Poorly correlated
-3.91%
WTF - MDBH
21%
Poorly correlated
+0.88%
CBOE - MDBH
20%
Poorly correlated
+2.79%
SPGI - MDBH
12%
Poorly correlated
+2.24%
FLD - MDBH
12%
Poorly correlated
-2.07%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RNAZ1.720.06
+3.31%
TransCode Therapeutics Inc
REGN819.0913.42
+1.67%
Regeneron Pharmaceuticals
WAY28.980.14
+0.49%
Waystar Holding Corp
LAB0.64-0.01
-2.22%
Standard BioTools
AZUL6.00-0.26
-4.15%
AZUL SA